School of Medicine
Showing 101-200 of 575 Results
-
Laura M.K. Dassama
Assistant Professor of Chemistry and of Microbiology and Immunology
BioLaura Dassama is a chemical biologist who uses principles from chemistry and physics to understand complex biological phenomena. Her group’s primary goal is to use detailed understanding of the factors that enable interactions between biological molecules to provide insights that allow functional control of those molecules. Her research projects aim to 1) discover the drivers of biomolecular interactions and 2) leverage that information to modulate disease relevant proteins.
-
Somalee Datta
Rsch Technical Mgr 3, Technology & Digital Solutions
Current Role at StanfordI am part of the Research Technology Team at Technology & Digital Solutions (TDS). I support research at Stanford Medicine. I joined Stanford in Oct 2012. Past experiences include Director of Bioinformatics at Stanford Center for Genomics and Personalized Medicine (SCGPM), and Director of Research IT at IRT/TDS.
-
Tami Daugherty, MD
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Daugherty is a transplant Hepatologist with full-time clinical responsibilities. She is particularly interested in the natural course and management of recurrent Hepatitis C after liver transplant, and the effect of immunosuppression on HCV recurrence.
-
Reinhold Dauskardt
Ruth G. and William K. Bowes Professor in the School of Engineering
BioDauskardt and his group have worked extensively on integrating new materials into emerging technologies including thin-film structures for nanoscience and energy technologies, high-performance composite and laminates for aerospace, and on biomaterials and soft tissues in bioengineering. His group has pioneered methods for characterizing adhesion and cohesion of thin films used extensively in device technologies. His research on wound healing has concentrated on establishing a biomechanics framework to quantify the mechanical stresses and biologic responses in healing wounds and define how the mechanical environment affects scar formation. Experimental studies are complimented with a range of multiscale computational capabilities. His research includes interaction with researchers nationally and internationally in academia, industry, and clinical practice.
-
Sujal Dave
Postdoctoral Scholar, Cardiology
BioSujal Dave, PhD, is a Postdoctoral Scholar in the Cardiovascular Biomechanics Computation Lab at Stanford University.
He recently completed his Ph.D. in Mechanical Engineering at the University of Calgary under the supervision of Dr. Artem Korobenko, where he developed consistent reduced order modeling frameworks for turbulent flows using variational multiscale methods and stabilized finite elements. His doctoral research advanced large-scale wind turbine wake simulations with applications to renewable energy and environmental flows. -
Guido A. Davidzon
Clinical Professor, Radiology - Rad/Nuclear Medicine
BioDr. Guido Alejandro Davidzon is a Clinical Professor of Radiology in Nuclear Medicine at the Stanford University School of Medicine. He currently serves as Director of Nuclear Cardiology at Stanford Health Care and is the Chair of the Radioactive Drug Research Committee.
Dr. Davidzon is a physician-scientist, educator, and leader whose work bridges clinical innovation, academic leadership, and translational research. His research focuses on the development and clinical translation of novel radiopharmaceuticals for use in oncology, neurodegeneration, cardiology, and pain imaging. He is also actively integrating AI-driven analytics and machine learning tools into molecular imaging to advance precision diagnostics and therapeutic decision-making.
His clinical and academic efforts include advancing theranostics, PET-based biomarker discovery, and the adoption of emerging imaging technologies in patient care. Dr. Davidzon is deeply committed to mentorship and the training of the next generation of imaging specialists and nuclear medicine professionals. -
Jenna Davis
Professor of Civil and Environmental Engineering, of Environmental Social Sciences and Higgins-Magid Senior Fellow at the Woods Institute
Current Research and Scholarly InterestsProfessor Davis’ research and teaching deals broadly with the role that water plays in promoting public health and economic development, with particular emphasis on low- and middle-income countries. Her group conducts applied research that utilizes theory and analytical methods from public and environmental health, engineering, microeconomics, and planning. They have conducted field research in more than 20 countries, most recently including Zambia, Bangladesh, and Kenya.
-
Kara Davis
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
-
Kiera Davis
Casual Employee, Med/Stanford Center for Clinical Research
Current Role at StanfordClinical Associate Director, Education & Training
Program Lead, SHC Tri-Valley Program Management Office (PMO) -
Mark M. Davis
Burt and Marion Avery Family Professor
Current Research and Scholarly InterestsMolecular mechanisms of lymphocyte recognition and differentiation; Systems immunology and human immunology; vaccination and infection.
-
Ronald W. Davis
Professor of Biochemistry and of Genetics
Current Research and Scholarly InterestsWe are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion.
-
Seth J. Davis, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsDr. Davis’ research interests include novel treatments for post-facial paralysis management, clinical outcomes in revision rhinoplasty and complex nasal reconstruction, and development of global health educational initiatives. He has presented grant funded, award winning research at dozens of conferences both locally and internationally. He has also published in a wide variety of high-impact journals, including Annals of Oncology, The Laryngoscope, and Facial Plastic Surgery & Aesthetic Medicine.
-
Kristen Davis-Lopez, MPH, PMP
S-SPIRE Project Manager, Stanford-Surgery Policy Improvement Research and Education Center
BioKristen Davis-Lopez, MPH, PMP is the Research Project Manager at the S-SPIRE Center. She has a background in biology as well as public health. She supports multiple principal investigators with their current funded projects as project manager. She leads the Social Science Research Professionals in the S-SPIRE Center and also assists with the grant submission process within the Department of Surgery acting as a liaison with the Research Management Group.
-
Aaron J. Dawes, MD, PhD, FACS, FASCRS
Assistant Professor of Surgery (General Surgery)
BioDr. Dawes is a board-certified, fellowship-trained colon and rectal surgeon. He is also an Assistant Professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Dawes treats a wide variety of conditions involving the colon, rectum, and anus, always leveraging the latest evidence and technologies. He is fully trained in minimally invasive surgical techniques--including laparoscopic, robotic, and trans-anal minimally invasive surgery--and strives to employ them, whenever possible, in an effort to reduce pain and shorten recovery.
In addition to his clinical work, Dr. Dawes is a health services researcher, receiving his Ph.D. in Health Policy and Management from the UCLA Fielding School of Public Health. His research focuses on policy development, measurement, and evaluation for patients with colorectal conditions. He is particularly interested in using data to drive policy interventions aimed at reducing disparities in quality, access, and value.
Prior to joining Stanford, Dr. Dawes completed a residency in General Surgery at the University of California, Los Angeles followed by a fellowship in Colon and Rectal Surgery at the University of Minnesota. He has authored articles in the Journal of the American Medical Association (JAMA), Cancer, Diseases of the Colon and Rectum, Health Services Research, and JAMA Surgery. His work has also been featured in the Los Angeles Times, the Daily Press, and HealthDay News.
A native of the San Francisco Bay Area, Dr. Dawes received his A.B. in Public and International Affairs from Princeton University and his M.D. from Vanderbilt University. -
Brian Dawes
Fellow in Medicine - Med/Infectious Diseases
Current Research and Scholarly InterestsMy current research is focused on better understanding the causes of acute febrile illness in Grenada in collaboration with the Windward Research and Education Foundation (WINDREF). We are conducting an acute febrile illness cohort and performing diagnostics for common arboviral infections including dengue, Zika, and chikungunya viruses. We will use this data to develop better estimates for the incidence of arboviral infections on the island and identify epidemiologic risk factors which could be the target of preventative interventions. This study is also assessing a novel diagnostic system for antigen detections in collaboration with Dr. Ali Yanik at UCSC. We will be testing these samples for hantavirus infections or antibodies to determine if hantaviral infections are clinically important causes of disease in Grenada. In addition, we are performing a pilot ecologic survey of rodents and bats and will attempt to identify circulating hantaviruses in these species.
-
Braden Michael Dawson
Affiliate, Radiology
BioBraden Dawson is an undergraduate student at the University of Southern California studying Legal Studies and Natural Science on pre-medical and pre-law tracks. His work focuses on health policy, healthcare systems, and translational medicine, with interests in healthcare access, implementation, and regulatory design. At Stanford School of Medicine, he is a Canary CREST Research Fellow, conducting translational cancer early-detection research under Parag Mallick, PhD.
-
Heather Sydney Day, MS
Biostatistician 2, Stanford-Surgery Policy Improvement Research and Education Center
Current Role at StanfordBiostatistician 2, Stanford-Surgery Policy Improvement Research and Education Center
-
John W. Day, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
On Partial Leave from 02/15/2026 To 10/18/2026Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
John Robert Dayton
Clinical Assistant Professor, Emergency Medicine
BioBefore becoming an assistant professor, Dr. Dayton was the inaugural Medical Design and Innovation Fellow with Stanford's Department of Emergency Medicine. He also completed a Biodesign Faculty Fellowship with the Byers Center for Biodesign. In addition to practicing medicine, he co-founded the Stanford Emergency Medicine Partnership Program (STEPP), directed two Stanford Emergency Medicine Innovation Symposium (StEMIX) pitch events, and led the 2022 ACEP Hackathon.
Outside of Stanford, Dr. Dayton advises health-tech companies on strategy and physician user experience and works in VC. He co-founded Utah's Society of Physician Entrepreneurs and has served in both state and national leadership positions with the American College of Emergency Physicians (ACEP). He also works with Intermountain Health as an emergency physician and physician advisor to Intermountain Ventures and is a life science investor with Frame VC.
John's areas of expertise include digital therapeutics, healthcare innovation, AI operational tools, medical devices, clinical validation, academic-private pilot partnerships, and venture funding. -
Aglaia Kaissa de Boer
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioKaïssa de Boer, MD is a board certified pulmonologist who specializes in the care of patients with interstitial lung disease. She completed her Internal Medicine and Pulmonary training at the University of Ottawa, Ottawa, Canada where her initial interest in caring for patients with fibrotic lung disease first developed. Subsequently she completed a fellowship in Interstitial Lung Disease at the University of California, San Francisco under the direction of Dr. Harold Collard. Dr. de Boer has a special interest in patients with connective tissue disease associated lung disease and those with drug induced pneumonitis. In addition she is actively involved in the ILD training and program development of Stanford's Pulmonary Allergy and Critical Care Fellows.
-
Walter De Brouwer
Adjunct Professor, Medicine - Primary Care and Population Health
BioWalter A. De Brouwer, Ph.D., is an Adjunct Professor at the Stanford School of Medicine. As a core faculty member at CERC DICE, he is the course director for “Innovation in Healthcare: from idea to incorporation,” which includes a bi-weekly presentation. He also serves on the advisory committee focused on the strategic direction for the program and is part of the leadership team developing the program curriculum and practicum. He is the founder of doc.ai, a Palo-Alto-based Federated Edge Learning company for the payers/pharma industry which merged in January 2020 with Sharecare Inc.
Professional Education
Bachelor’s degree in Philology (University of Ghent, Belgium)
Master’s degree in Formal Linguistics (University of Ghent, Belgium)
Post-graduate: Epistemology (University of Ghent, Belgium)
Ph.D. Computational Semiotics (Catholic University of Tilburg, the Netherlands). -
Korina De Bruyne
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.
-
Sallie De Golia
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is Director of Coaching and Senior Faculty Educational Consultant in Stanford's Department of Psychiatry and Behavioral Sciences. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Michelle de Haaff
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Director of Digital Health
Co-Instructor Biodesign for Digital Health (Fall) and Biodesign for Societal Health (Winter)
Stanford Byers Center for Biodesign -
Vinicio de Jesus Perez MD
Associate Dean of Stanford MD Admissions and Professor of Medicine (PACCM)
Current Research and Scholarly InterestsMy work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.
-
Francisco M. De La Vega
Adjunct Professor, Biomedical Data Science
BioFrancisco De La Vega is a distinguished geneticist and computational biologist, and an experienced technical executive, widely recognized for his expertise in clinical and population genomics, and bioinformatics. Currently serving as the Vice President of Hereditary Disease at Tempus Labs, Francisco is spearheading the development of comprehensive germline genetic tests and conducting innovative research into racial disparities in cancer leveraging Tempus’ multimodal Real-World Data. His work focuses on uncovering the connections between genetic ancestry and cancer genome mutational profiles that may help explain the differences in cancer incidence and outcomes across races and ethnicities. In addition to his role at Tempus Labs, Francisco is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University School of Medicine and is a member of the Board of Directors of the International Society of Computational Biology, serving from 2022 to 2025.
Francisco teaches BIODS-235: "Best practices for developing data science software for clinical and healthcare applications" every Winter quarter. -
Adam de la Zerda
Associate Professor of Structural Biology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsMolecular imaging technologies for studying cancer biology in vivo
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Carolina Temer de Sá
Adm Svcs Admstr 1, School of Medicine - Office of Academic Affairs
BioCaro de Sá is a Research and Program Officer in Stanford Medicine’s Office of Faculty Development and Engagement. In this role, they evaluate and support existing faculty development and engagement programs within the office, create content that promotes inclusivity within academic medicine, and assist with planning for events and initiatives in the School of Medicine. Caro obtained their BA in Comparative Studies in Race and Ethnicity from Stanford University, where they focused on community-building through arts-based practices, cooperative living spaces, and queer-affirming organizations.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Charles DeBattista
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
On Partial Leave from 10/01/2025 To 10/01/2026Current Research and Scholarly InterestsTreatment resistant depression.
Novel biological interventions in the treatment of mental illness.
Anti-glucocorticoid drugs in the treatment of mood disorders.
Augmentation strategies in the treatment of depression. -
Charles DeBoer, MD, PhD
Assistant Professor of Ophthalmology
BioDr. DeBoer is a board-certified, fellowship-trained vitreoretinal surgeon with Stanford Health Care’s Byers Eye Institute and a clinical instructor in the Department of Ophthalmology.
He specializes in retinal and macular diseases, treating a range of conditions such as retinal tears, diabetic retinopathy, retinal vein occlusions, macular pucker, macular hole, macular degeneration, retinal detachment, and other complex retinal conditions. Dr. DeBoer incorporates state-of-the-art treatments in personalized, comprehensive care plans for each of his patients. He is dedicated to training future vitreoretinal surgeons and passionate about helping patients through both direct care and research.
Dr. DeBoer’s scientific background in micro- and nanofabrication, mechanical and electrical engineering, and medicine drives his research interests in implantable devices and surgical instruments. While completing his PhD, Dr. DeBoer co-invented a biomimetic accommodating intraocular lens (IOL) that treats both cataracts and presbyopia.
He continues researching microdevices, focusing on extended drug delivery from the lens capsule and microelectromechanical systems (MEMS)-enabled implantable devices. Dr. DeBoer’s research experience spans topics such as material science, drug delivery, IOL design, microfabrication, 3D printing, and medical device design. He has received grant funding for his work and has 12 patents in the field of ophthalmology.
Dr. DeBoer’s work has been published in peer-reviewed journals, including the American Journal of Ophthalmology. He has authored book chapters and presented to his peers at national and international meetings, including meetings of the American Society of Retina Specialists and the Association for Research in Vision and Ophthalmology.
Dr. DeBoer is a member of the American Academy of Ophthalmology and American Society of Retina Specialists. He is also part of the Society of HEED Fellows and Ronald G. Michels Fellowship Foundation. -
Robert DeBusk
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsExperimental and clinical epidemiology of myocardial, infarction; exercise testing; cardiac risk factor management;, cardiac rehabilitation; systems for patient management; ischemic, heart disease; computer-based expert systems.
-
Johannes Hugo Decker
Clinical Assistant Professor, Radiology
BioHugo Decker is part of the Diagnostic Radiology resident call of 2018-2022.
He received his BS in Biological Sciences at Stanford in 2008.
He completed his MSTP training at Weill Cornell Medical College in 2017.
He completed his Medical internship at Santa Clara Valley Medical Center in 2018. -
Niki DeGeorge
Associate Director of Radiation Physics, Radiation Oncology
Current Role at StanfordNiki is the Associate Director of Radiation Physics in the Department of Radiation Oncology.
-
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Cornelia L. Dekker, M.D.
Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Current Research and Scholarly InterestsThe Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.
-
Tina M. Del Cont
Product & Program Manager, Stanford Profiles, Technology & Digital Solutions
Current Role at StanfordI am the Product Manager for Stanford Profiles and Project Manager of the Stanford Profiles University-Wide Project. I work directly with the Stanford Profiles development team in Stanford Medicine | Technology & Digital Solutions Application Development. On this project, I also work with a university-wide project team, the Stanford Profiles (formerly CAP) Working Group, made up of members from many of the Stanford schools and organizations. In June of 2014, we started the CAP Drupal Module Working Group. The purpose of this group is to review and improve the integration process with CAP by expanding and enhancing the CAP Drupal Module (CAPx) with an open-source contribution approach (an initiative started and led by SWS in collaboration with the CAP Drupal Module user community).
If you are interested in becoming part of the Stanford Profiles University-Wide Project, which includes the Stanford Profiles Public and Stanford-only View web sites or would like more information on integrating your web site with Stanford Profiles, contact me at tdelcont@stanford.edu. -
Claudia Del Toro Runzer
Postdoctoral Scholar, Medical Genetics
BioClaudia Del Toro Runzer is a postdoctoral scholar at Stanford University specializing in gene therapy and regenerative medicine. Her current research focuses on developing gene editing strategies for inherited disorders, including GNE myopathy and Gaucher disease. She works on advancing precision gene engineering approaches in human hematopoietic stem and progenitor cells and other clinically relevant cell types, with the goal of enabling safe and durable therapeutic correction.
Dr. Del Toro Runzer earned her PhD in Tissue Engineering from the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University. Her doctoral research focused on chemically modified mRNA therapeutics for bone regeneration, where she investigated molecular design, intracellular trafficking, and biomaterial-assisted delivery systems to enhance protein expression and osteogenic outcomes. Her work resulted in multiple first-author publications in leading journals, including Advanced Functional Materials, Bone Research, Materials Today, and Molecular Therapy: Nucleic Acids.
Prior to her PhD, she completed an M.Sc. in Regenerative Biology and Medicine at Technische Universität Dresden and a B.Sc. in Biotechnology Engineering at Instituto Tecnológico de Monterrey. Her international training spans Germany, the Netherlands, Mexico, and the United States, with research experience in organoid systems, tissue regeneration, biomaterials engineering, and microphysiological platforms. -
Erlynn Dela Cruz
Administrative Associate, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate
